Novartis
NVS
#59
Rank
$195.49 B
Marketcap
$94.53
Share price
1.08%
Change (1 day)
-3.42%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - P/B ratio

P/B ratio as of April 2024 : 4.14

According to Novartis's latest financial reports the company has a price-to-book ratio of 4.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novartis - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-314.4435.19%
2022-12-313.2813.36%
2021-12-312.90-24.62%
2020-12-313.84-0.63%
2019-12-313.8754.26%
2018-12-312.51-5.63%
2017-12-312.6615.01%
2016-12-312.31-14.55%
2015-12-312.70-14.52%
2014-12-313.1620.99%
2013-12-312.6118.84%
2012-12-312.205.02%
2011-12-312.098.56%
2010-12-311.93-11.35%
2009-12-312.18-2.62%
2008-12-312.23-10.26%
2007-12-312.49-23.78%
2006-12-313.27-11.63%
2005-12-313.70-5.62%
2004-12-313.925.55%
2003-12-313.7115.66%
2002-12-313.21

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.17 24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1.64-60.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.88 17.86%๐Ÿ‡บ๐Ÿ‡ธ USA
1.41-65.84%๐Ÿ‡ซ๐Ÿ‡ท France
8.46 104.56%๐Ÿ‡บ๐Ÿ‡ธ USA
3.32-19.78%๐Ÿ‡บ๐Ÿ‡ธ USA
5.46 31.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.12 23.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.92-53.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel